Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis

Abstract Introduction There remains uncertainty about whether transitioning to oral antibiotic therapy is appropriate for the management of children with methicillin-resistant Staphylococcus aureus (MRSA) bacteremic osteomyelitis. We compared clinical outcomes for children with MRSA osteomyelitis wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jared Olson, Rana F. Hamdy, Alice J. Hsu, Pranita D. Tamma, Jeffrey S. Gerber, Nora F. Fino, Adam L. Hersh
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40121-024-01074-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571484410740736
author Jared Olson
Rana F. Hamdy
Alice J. Hsu
Pranita D. Tamma
Jeffrey S. Gerber
Nora F. Fino
Adam L. Hersh
author_facet Jared Olson
Rana F. Hamdy
Alice J. Hsu
Pranita D. Tamma
Jeffrey S. Gerber
Nora F. Fino
Adam L. Hersh
author_sort Jared Olson
collection DOAJ
description Abstract Introduction There remains uncertainty about whether transitioning to oral antibiotic therapy is appropriate for the management of children with methicillin-resistant Staphylococcus aureus (MRSA) bacteremic osteomyelitis. We compared clinical outcomes for children with MRSA osteomyelitis with associated bacteremia who were transitioned to discharge oral antibiotic therapy to those discharged on outpatient parenteral antibiotic therapy (OPAT). Methods We performed a retrospective, multicenter, cohort study of children ≤ 18 years hospitalized with MRSA bacteremic osteomyelitis across four children’s hospitals from 2007 to 2018 discharged on oral antibiotic therapy versus OPAT. The primary outcome was treatment failure within 6 months of discharge, defined as any of the following: diagnosis of chronic osteomyelitis, conversion from oral to IV antibiotic route, an operative procedure after the index hospitalization (abscess drainage, bone biopsy, arthrocentesis, or pathologic fracture) and/or recrudescence of MRSA bacteremia. Outcomes were analyzed in an inverse propensity score weighted (IPW) cohort. Results A total of 106 cases of MRSA bacteremic osteomyelitis were included; 44 (42%) were discharged in the oral antibiotic therapy group and 62 (59%) patients were discharged in the OPAT group. In the IPW cohort, treatment failure within 6 months of discharge occurred in 3.4% of children in the discharge oral therapy group and 16.3% in the OPAT group (P = 0.03). The odds of 6-month composite treatment failure between discharge oral therapy and OPAT were 0.18 (95% CI 0.05–0.61). Conclusions Discharge oral therapy was not associated with higher rates of treatment failure compared to OPAT for children with MRSA bacteremic osteomyelitis.
format Article
id doaj-art-e833600654a742cd992e7d75e7bc4a00
institution Kabale University
issn 2193-8229
2193-6382
language English
publishDate 2024-11-01
publisher Adis, Springer Healthcare
record_format Article
series Infectious Diseases and Therapy
spelling doaj-art-e833600654a742cd992e7d75e7bc4a002025-02-02T12:35:15ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822024-11-01141819010.1007/s40121-024-01074-2Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic OsteomyelitisJared Olson0Rana F. Hamdy1Alice J. Hsu2Pranita D. Tamma3Jeffrey S. Gerber4Nora F. Fino5Adam L. Hersh6Department of Pharmacy, Primary Children’s HospitalDepartment of Pediatrics, Children’s National HospitalDepartment of Pharmacy, The Johns Hopkins HospitalDepartment of Pediatrics, The Johns Hopkins University School of MedicineDepartment of Pediatrics, Children’s Hospital of PhiladelphiaDivision of Epidemiology, Department of Internal Medicine, University of UtahDivision of Infectious Diseases, Department of Pediatrics, University of UtahAbstract Introduction There remains uncertainty about whether transitioning to oral antibiotic therapy is appropriate for the management of children with methicillin-resistant Staphylococcus aureus (MRSA) bacteremic osteomyelitis. We compared clinical outcomes for children with MRSA osteomyelitis with associated bacteremia who were transitioned to discharge oral antibiotic therapy to those discharged on outpatient parenteral antibiotic therapy (OPAT). Methods We performed a retrospective, multicenter, cohort study of children ≤ 18 years hospitalized with MRSA bacteremic osteomyelitis across four children’s hospitals from 2007 to 2018 discharged on oral antibiotic therapy versus OPAT. The primary outcome was treatment failure within 6 months of discharge, defined as any of the following: diagnosis of chronic osteomyelitis, conversion from oral to IV antibiotic route, an operative procedure after the index hospitalization (abscess drainage, bone biopsy, arthrocentesis, or pathologic fracture) and/or recrudescence of MRSA bacteremia. Outcomes were analyzed in an inverse propensity score weighted (IPW) cohort. Results A total of 106 cases of MRSA bacteremic osteomyelitis were included; 44 (42%) were discharged in the oral antibiotic therapy group and 62 (59%) patients were discharged in the OPAT group. In the IPW cohort, treatment failure within 6 months of discharge occurred in 3.4% of children in the discharge oral therapy group and 16.3% in the OPAT group (P = 0.03). The odds of 6-month composite treatment failure between discharge oral therapy and OPAT were 0.18 (95% CI 0.05–0.61). Conclusions Discharge oral therapy was not associated with higher rates of treatment failure compared to OPAT for children with MRSA bacteremic osteomyelitis.https://doi.org/10.1007/s40121-024-01074-2Acute osteomyelitisMethicillin-resistant Staphylococcus aureusBacteremia
spellingShingle Jared Olson
Rana F. Hamdy
Alice J. Hsu
Pranita D. Tamma
Jeffrey S. Gerber
Nora F. Fino
Adam L. Hersh
Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
Infectious Diseases and Therapy
Acute osteomyelitis
Methicillin-resistant Staphylococcus aureus
Bacteremia
title Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
title_full Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
title_fullStr Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
title_full_unstemmed Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
title_short Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis
title_sort association of antibiotic route and outcomes in children with methicillin resistant staphylococcus aureus bacteremic osteomyelitis
topic Acute osteomyelitis
Methicillin-resistant Staphylococcus aureus
Bacteremia
url https://doi.org/10.1007/s40121-024-01074-2
work_keys_str_mv AT jaredolson associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT ranafhamdy associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT alicejhsu associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT pranitadtamma associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT jeffreysgerber associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT noraffino associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis
AT adamlhersh associationofantibioticrouteandoutcomesinchildrenwithmethicillinresistantstaphylococcusaureusbacteremicosteomyelitis